Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant Zoster Vaccine (CHO cell) Phase II in Adults 50–70
CTR20220766Phase 2Completed
- Sponsor
- Green Bamboo Bio
- Start
- Apr 2022
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of Zoster vaccine recombinant in herpes zoster (HZ), Varicella zoster infection, sponsored by Green Bamboo Bio. Started Apr 2022; status: completed.
02
Drugs
Zoster vaccine recombinant
03
Conditions
herpes zoster (HZ)Varicella zoster infection
Beyond the preview
Go deeper on CTR20220766.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20220766.